Elecsys Anti-HAV IgM assay-for the in vitro qualitative detection of IgM antibodies to hepatitis A virus (anti-HAV IgM) in human serum and plasma Catalog number: 07026773190
Published December 18, 2019 · Recall initiated: October 28, 2019
Summary
FDA records medical device Class II recall Z-0669-2020, published December 18, 2019 and initiated October 28, 2019. Recalling firm: Roche Diagnostics Operations, Inc.; Status: Terminated; Reported quantity: 712 units; Lot: Anti-HAV IgM APP-file (version 06.05-101). Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Current software version of the Anti-HAV IgM APP-file (version 06.05-101) downloaded an erroneous Border Area setting, (1.0 1.00) instead of (0.90 1.10).
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Roche Diagnostics Operations, Inc.
- Distributor
- US Nationwide distribution.
- Lot
- Anti-HAV IgM APP-file (version 06.05-101)
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAcobas HCYS, Homocysteine Enzymatic Assay, Material Number REF 06542921190, for use on cobas c 701/702, inNovember 27, 2024
- FDACreatine Kinase (CK) used on cobas c 311/501/502 and COBAS INTEGRA 400 plus-In vitro test for the quantitativeOctober 2, 2024
- FDAAlbumin Gen.2, Catalog 05166861190October 21, 2020
- FDAHealix Knotless ADV BR 4.75 Suture AnchorDecember 18, 2019
- FDABOND Polymer Refine Detection Kit, Catalog No. DS9800. This detection system is for in vitro diagnostic use.December 18, 2019
- FDAOnline TDM Vancomycin Gen.3 (100 tests) Catalog # 06779336190 Analyzer/Module: cobas c 311 and cobas c 501/502October 16, 2019
Questions about this recall
Was Elecsys Anti-HAV IgM assay-for the in vitro qualitative detection of IgM antibodies to hepatitis A virus (anti-HAV IgM) in human serum and plasma Catalog number: 07026773190 recalled?
Yes. FDA published recall Z-0669-2020 on December 18, 2019. Reported hazard: Current software version of the Anti-HAV IgM APP-file (version 06.05-101) downloaded an erroneous Border Area setting, (1.0 1.00) instead of (0.90 1.10).
What should I do if I have this product?
Voluntary: Firm initiated · Letter